Business ❯ Finance ❯ Mergers and Acquisitions

Pharmaceutical Industry

Torrent Pharmaceuticals AstraZeneca and Bristol Myers Squibb Merger AstraZeneca Sun Pharmaceutical Vertex Pharmaceuticals AstraZeneca and Bristol Myers Squibb Chemist Warehouse Company Acquisitions Corporate Transactions Mallinckrodt and Endo Merger Biotech Companies Merck & Co. J B Chemicals and Pharmaceuticals Generic Drugs Pfizer Acquisition of Metsera Novo Nordisk Pfizer Metsera Acquisition Strategies Market Dynamics Laboratory Acquisitions BioMarin Pharmaceutical Investment Astra Zeneca Psychedelic Drug Development Outbound Acquisitions Global Expansion Sun Pharmaceutical Industries Eli Lilly & Co. Market Expansion Outbound Deals Organon Acquisition Sun Pharma Acquisition Market Trends Long-term Care Pharmacy AbbVie Acquisition Bristol Myers Squibb Astrazeneca

AstraZeneca in Talks With Bristol Myers on Potential $400 Billion Merger

AstraZeneca's pursuit of greater U.S. scale could trigger intense antitrust scrutiny.

Vertex to Acquire Crinetics for About $10 Billion

Bankruptcy Court Clears CVS Sale of Omnicare to GenieRx for $250 Million

Angelini Pharma to Acquire Catalyst Pharmaceuticals for $4.1 Billion in Cash

Sun Pharma to Buy Organon for $11.75 Billion in All-Cash Deal

Lilly to Acquire Ajax Therapeutics in Up to $2.3 Billion Blood Cancer Deal

Sun Pharma Said to Make $13 Billion All-Cash Offer for Organon

Novartis Strikes $2 Billion Deal for Mutant-Selective PI3Kα Cancer Drug SNV4818

BioMarin to Acquire Amicus for $4.8 Billion in Cash